• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD (SUZHOU) BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD (SUZHOU) BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383033
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Skin Inflammation/ Irritation (4545)
Event Date 11/27/2022
Event Type  Injury  
Manufacturer Narrative
Date of birth: unknown.The patient¿s age was used to determine a placeholder date for this field.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after the bd intima-ii¿ closed iv catheter system was placed, the patient developed redness and swelling at the insertion site the following morning.Jinhuang powder was applied locally as a result.The following information was provided by the initial reporter, translated from chinese: "he was admitted to the hospital for 3 days due to chest tightness and breathlessness accompanied by fever, cough and sputum.On (b)(6) 2022, he was admitted to the internal medicine department.After admission, anti-infection symptomatic and supportive treatment was given, and an indwelling needle was placed for infusion.During the morning shift on (b)(6(, the patient complained of pain and discomfort in the arm where the injection was given.Check the local area immediately and find that the local skin is redness and swollen.That is, the indwelling needle was excluded, and jinhuang powder was applied locally.
 
Event Description
It was reported that after the bd intima-ii¿ closed iv catheter system was placed, the patient developed redness and swelling at the insertion site the following morning.Jinhuang powder was applied locally as a result.The following information was provided by the initial reporter, translated from chinese: "he was admitted to the hospital for 3 days due to chest tightness and breathlessness accompanied by fever, cough and sputum.On november 27, 2022, he was admitted to the internal medicine department.After admission, anti-infection symptomatic and supportive treatment was given, and an indwelling needle was placed for infusion.During the morning shift on (b)(6) the patient complained of pain and discomfort in the arm where the injection was given.Check the local area immediately and find that the local skin is redness and swollen.That is, the indwelling needle was excluded, and jinhuang powder was applied locally.
 
Manufacturer Narrative
H6: investigation summary a device history review was conducted for lot number 2188026.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Additionally, a sample could not be obtained for evaluation and testing, but this lot was treated and received a certificate of conformance for sterility.Unfortunately, without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.H3 other text : see h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer (Section G)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16103281
MDR Text Key306713914
Report Number3014704491-2022-00724
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number383033
Device Lot Number2188026
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
-
-